Related Experiment Video
Updated: Dec 19, 2025

09:03
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
9.1K
The development of ghost vaccines trials.
Ali M Batah1, Tarek A Ahmad2,3
1Tropical Disease Research Center, University of Science and Technology , Sana'a, Yemen.
Expert Review of Vaccines
|June 6, 2020
Summary
Bacterial ghosts, safe and antigen-preserving vaccine platforms, offer versatile applications. These bacterial envelopes are developed for use as vaccines, antigen carriers, and DNA delivery systems.
Area of Science:
- Biotechnology
- Vaccinology
- Immunology
Background:
- Bacterial ghosts are bacterial cell envelopes emptied of cellular contents.
- Ghost technology offers enhanced vaccine safety while preserving antigenicity.
- These platforms can express or carry antigens and DNA encoding epitopes.
Purpose of the Study:
- To review the development and applications of bacterial ghost vaccines over 30 years.
- To discuss how ghost vaccines stimulate the immune system, their benefits, and drawbacks.
- To categorize production methods and diverse applications of bacterial ghosts.
Main Methods:
- Classification of ghost vaccine production methods based on lysis patterns and bacterial types.
- Review of applications including killed vaccines, recombinant antigen platforms, and DNA carriers.
- Description of phage-mediated lysis and molecular manipulation of lysis genes.
Main Results:
- Bacterial ghosts serve as effective immune-presenting platforms for various vaccine types.
- Applications include alternative killed vaccines, recombinant antigen presentation, DNA vaccine delivery, and adjuvant use.
- The technology has evolved significantly, with ongoing molecular advancements.
Conclusions:
- Bacterial ghosts are highly qualified immune-presenting platforms.
- They are efficient as alternative killed vaccines and carriers for recombinant and DNA vaccines.
- Future molecular advancements will further enhance ghost production and antigen expression.
Related Concept Videos
Vaccinations
50.8K
Overview
50.8K
Development of Immunocompetence
662
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
662
Preclinical Development: Overview
5.6K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K
Microorganisms in Medicine and Therapeutics
821
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
821
Cancer Vaccines
868
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
868

